Gilead Sciences reported $1.22B in Cost of Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4341M 157M
Acorda Therapeutics ACOR:US $ 13.3M 1.98M
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
ALKERMES ALKS:US 49.56M 3.56M
Alnylam Pharmaceuticals ALNY:US $ 32.66M 2.41M
Amgen AMGN:US $ 1609M 28M
Biogen BIIB:US $ 511.8M 52.1M
Biomarin Pharmaceutical BMRN:US $ 103.54M 23.52M
Bluebird Bio BLUE:US $ 19.7M 4.4M
Bristol Myers Squibb BMY:US $ 2291M 160M
Coherus Biosciences CHRS:US $ 21.28M 4.58M
Eli Lilly And LLY:US $ 1430.8M 522.4M
Gilead Sciences GILD:US $ 1223M 167M
GlaxoSmithKline GSK:LN 2822M 303M
Glaxosmithkline GSK:US $ 2822M 303M
Intercept Pharmaceuticals ICPT:US $ 0.66M 0.04M
Johnson & Johnson JNJ:US $ 7250M 317M
Merk MRK:US $ 3056M 14M
Moderna Inc MRNA:US 722M 28M
Neurocrine Biosciences NBIX:US $ 4.2M 1.1M
Novartis NOVN:VX SF 3848M 94M
Pfizer PFE:US $ 9931M 2939M
Ptc Therapeutics PTCT:US $ 6.54M 0.82M
Puma Biotechnology PBYI:US $ 10.28M 1.69M
Regeneron Pharmaceuticals REGN:US $ 453.2M 240.5M
Sarepta Therapeutics SRPT:US $ 23.44M 3.93M
Teva Pharmaceutical Industries TEVA:US $ 1989M 2M
United Therapeutics UTHR:US $ 27.7M 9.5M
Vertex Pharmaceuticals VRTX:US $ 236.51M 8.54M
YTE INCY:US $ 34.47M 1.84M